Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT)

A Prospective, Randomised, Blinded, Placebo-controlled Pilot Study of the Treatment of Erectile Dysfunction With Extracorporeal Shockwave Therapy (ESWT)

The objective of the pilot study is to assess the feasibility of a full randomised, placebo-controlled clinical trial.The aim is to demonstrate that penile shockwave application in patients with erectile dysfunction of vascular origin leads to a greater increase in potency than in the control group.

Inclusion Criteria:

• Erectile dysfunction for more than 6 months
• Informed consent
• Positive effect of phosphodiesterase type 5 inhibitor (PDE5i)
• IIEF-15 score less than 20
• No neurological disease
• Stable partnership for more than 3 months
• Age 18-75

Exclusion Criteria:

• Total prostatectomy
• Another reason for ED except for vascular disorder
• Clinically significant hematological disease
• Heart stroke, Arrythmia during the last 6 months
• Cancer during the last 5 years
• Intake of antiandrogen
• ED treatment with the last 7 days
• IIEF score higher than, equal to 20
• Previous shockwave treatment